Altrazeal

Category:

Altrazeal 

A novel transforming powder wound dressing. Lyophilised powder hydrates and aggregates irreversibly when exposed to exudate forming a micro-porous skin-like barrier. 84.8% poly-2-hydroxyethylmethacrylate (pHEMA), 14.9% poly-2-hydroxypropylmethacrylate (pHPMA), and 0.3% sodium deoxycholate. Polymer spheres create a honeycomb structure.
Micro-pores create capillary forces 1: allowing oxygen transportation, managing exudate through vapour transpiration, creating decreased pressure at the wound bed. Material is non-resorbable and Sterilised by irradiation.

 
The Action Altrazeal® powder consists of polymer particles with inherent properties to support cellular function. Powder rapidly absorbs exudate transforming into a micro-porous skin-like barrier. Pores are too small for bacteria to penetrate. The material is non-resorbable and maintains intimate contact with the wound bed. Negative pressure at the wound bed.

The Benefits 
-Micro-contouring to the moist wound bed without bio-adhesion
-High MVTR (12L per metre squared in 24 hrs) with low pressure at the wound-dressing interface stimulating healthy granulation tissue
-Impermeable to bacteria
-Continuous total moisture content of 68% at the wound surface
-Decreased risk of peri-wound maceration
-Flexibility with tensile strength
-Improved patient comfort with improvements in pain levels
-Secondary dressing may not be required
-Use for 7 days; can remain in place up to 30 days if exudate is present